Navigation Links
Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007
Date:11/20/2007

HAIFA, Israel, November 20 /PRNewswire-FirstCall/ --

- Third quarter Consolidated Net Income NIS 178 Million, Compared to NIS 24 Million Last Year; Third Quarter 2006 Results Adversely Affected by Northern Hostilities

- Company Publishing Today Hebrew Draft Prospectus for the Issue of Debentures Primarily for the Financing of the Strategic Plan; Debentures Were Rated AA Stable by Maalot, a Standard and Poor's Affiliation

Oil Refineries Ltd. (TASE: ORL) ("Oil Refineries" or the "Company") announced today its financial results for three and nine-month periods ending September 30, 2007.

The reported results for the third quarter and nine months 2007 exclude the results of Ashdod Refineries, which was sold at the end of the third quarter 2006, and which generated a substantial capital gain in the said third quarter. The results for the comparable period, the third quarter and nine months of 2006, are pro-forma figures and refer to the consolidated pro-forma statements.

Third Quarter Highlights

- Refining margin USD/bbl 5.7, compared to USD/bbl 7.3 in the third quarter 2006

- Company refining margin 52% higher than Mediterranean Ural Cracking Margin average of USD/bbl 3.75

- Consolidated EBITDA totaled NIS 326, compared to NIS 144 million in third quarter 2006

- Consolidated net income totaled NIS 178 million, compared to 24 million in third quarter 2006

- Quarterly results positively affected by the changes in the USD against the Israeli Shekel; Last year's third quarter results were negatively affected by the northern hostilities

Third Quarter Results

Refining margin for the third quarter totaled USD/bbl 5.7 (USD/MT 41.6), compared to the third quarter Mediterranean Ural Cracking Margin(i) average of USD/bbl 3.75(i) (USD/MT 27.4). Refining margin for the third quarter 2006 totaled USD/bbl 7.3 (USD/MT 52.9).

Consolidated EBITDA for the third quarter 2007 reached NIS 326 million, compare
'/>"/>

SOURCE Oil Refineries Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...irstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharm...ingnovelpainmanagementtherapies,announcedtodaythat...sscheduledtopresentatthe21stAnnualPiperJaffrayHeal...orkPalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoa...ilabletorespondtoquestionsduringthepresentationsan...
(Date:11/24/2009)...approved the Promega PowerPlex 16 HS System for us...NA records for the National DNA Index System. , ...The FBI recently approved the Promega PowerPlex&r...ating in, or generating DNA records for, the Natio...ns more than seven million profiles and has assist...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...-HealthRoboticstodayannounced,thatithasformedanewC...ThisrecentlyformedToronto-basedcompanywilloperateu...,install,andsupport,HealthRobotics,i.v.RoomoftheFu...fferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,H...an"asneeded,basis"toitsstrategicpartnershipswithMc...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... , , Convenient form...provided , Optimized for highest y...iciency , Complete with SUPERaseIn R...ontrol , Ideal for microinjection, in... , The mMESSAGE mMACHINE Hi...
... Small Interfering RNAs (siRNAs) are , ... can target complementary , mRNAs for...erference , (RNAi) (Elbashir et al., ... the use of vectors expressing functional s... studies (for a review, see Tuschl, 2002). Two dif...
... , Rapid Amplification of cDNA end... reaction-based technique developed to facilitate ...sages (see <A , href="http://www.am..., the 5,-End?" ). Ambion,s FirstChoic...ment to the basic RACE protocol. The procedure spe...
Other Biology Technology:Rapidly Synthesize Large Amounts of Capped RNA 2Rapidly Synthesize Large Amounts of Capped RNA 3Rapidly Synthesize Large Amounts of Capped RNA 4More siRNA Vectors for RNA Interference 2More siRNA Vectors for RNA Interference 3More siRNA Vectors for RNA Interference 4More siRNA Vectors for RNA Interference 5More siRNA Vectors for RNA Interference 6More siRNA Vectors for RNA Interference 7Get the 5'-End 2Get the 5'-End 3Get the 5'-End 4Get the 5'-End 5Get the 5'-End 6Get the 5'-End 7
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...ber 24, 2009) -- The Wildlife Conservation Society... last remaining population of Siberian tigers has ...de of poaching and habitat loss. , W...als of what needs to be done to protect remaining ... The report was released by the Siberian Tig...
(Date:11/24/2009)...Spanish . , The presence of increased body f...bstances in the blood, hinders the loss and mainte...ct of the University of Navarra conducted by Estba...Pharmacy. , The project, entitled "A nutrigeneti...l of body weight and inflammation," examines how t...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2United States Olympic Committee Announces D I S C Sports and Spine Center as an Official Medical Services Provider 60972 1United States Olympic Committee Announces D I S C Sports and Spine Center as an Official Medical Services Provider 60972 2United States Olympic Committee Announces D I S C Sports and Spine Center as an Official Medical Services Provider 60972 3Guardian Disability Insurance Brokerage Establishes The Best Way To Start New Agents 60968 1Guardian Disability Insurance Brokerage Establishes The Best Way To Start New Agents 60968 2St Jude Childrens Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 60964 1St Jude Childrens Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 60964 2St Jude Childrens Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 60964 3St Jude Childrens Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial 60964 4
...ed to cocaine have an impaired ability to perceive...n the brain,s reward and control circuits, accordi...sychological tests conducted at the U.S. Departmen...ur findings provide the first evidence that the br... is modified in drug-addicted people, and is direc...
...have high blood sugar before undergoing surgery ru...p vein thrombosis and even pulmonary embolism afte...sor of anesthesiology in the Artificial Pancreas C...rson University in Philadelphia, and his colleague...lacement surgery patients at Thomas Jefferson Univ...
...offers tantalizing clues as to why some teenagers ...ressive or kill themselves. The research is publi... is published by the American Psychological Associ...f Texas at Austin found that juvenile hamsters giv... sold in the United States as Prozac, became more ...
Other Biology News:Altered perception of reward in human cocaine addiction 2Altered perception of reward in human cocaine addiction 3Jefferson scientists find high glucose before surgery raises risk of dangerous complications 2Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2
HeavyPeptide AQUA Custom4 Kit from Thermo Scientific
PxE Thermal Cycler from Thermo Scientific
...Thermo Electron's most advanced personal gradient ...ticated onboard software and a large graphical dis...rmance, accuracy and simplicity in thermal cycling... features built up on years of PCR experience. The...
HeavyPeptide AQUA Demo Kit from Thermo Scientific
Biology Products: